Literature DB >> 8499816

Abnormalities of sleep in patients with the chronic fatigue syndrome.

R Morriss1, M Sharpe, A L Sharpley, P J Cowen, K Hawton, J Morris.   

Abstract

OBJECTIVE: To determine whether patients with the chronic fatigue syndrome have abnormalities of sleep which may contribute to daytime fatigue.
DESIGN: A case-control study of the sleep of patients with the chronic fatigue syndrome and that of healthy volunteers.
SETTING: An infectious disease outpatient clinic and subjects' homes.
SUBJECTS: 12 patients who met research criteria for the chronic fatigue syndrome but not for major depressive disorder and 12 healthy controls matched for age, sex, and weight. MAIN OUTCOME MEASURES: Subjective reports of sleep from patients' diaries and measurement of sleep patterns by polysomnography. Subjects' anxiety, depression, and functional impairment were assessed by interview.
RESULTS: Patients with the chronic fatigue syndrome spent more time in bed than controls (544 min v 465 min, p < 0.001) but slept less efficiently (90% v 96%, p < 0.05) and spent more time awake after initially going to sleep (31.9 min v 16.6 min, p < 0.05). Seven patients with the chronic fatigue syndrome had a sleep disorder (four had difficulty maintaining sleep, one had difficulty getting to sleep, one had difficulty in both initiating and maintaining sleep, and one had hypersomnia) compared with none of the controls (p = 0.003). Those with sleep disorders showed greater functional impairment than the remaining five patients (score on general health survey 50.4% v 70.4%, p < 0.05), but their psychiatric scores were not significantly different.
CONCLUSIONS: Most patients with the chronic fatigue syndrome had sleep disorders, which are likely to contribute to daytime fatigue. Sleep disorders may be important in the aetiology of the syndrome.

Entities:  

Mesh:

Year:  1993        PMID: 8499816      PMCID: PMC1677618          DOI: 10.1136/bmj.306.6886.1161

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  18 in total

1.  Maintenance treatment in recurrent depression: current and future directions. The first William Sargant Lecture.

Authors:  D J Kupfer
Journal:  Br J Psychiatry       Date:  1992-09       Impact factor: 9.319

2.  Musculosketal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects.

Authors:  H Moldofsky; P Scarisbrick; R England; H Smythe
Journal:  Psychosom Med       Date:  1975 Jul-Aug       Impact factor: 4.312

3.  Sleep and posttraumatic rheumatic pain modulation disorder (fibrositis syndrome).

Authors:  P Saskin; H Moldofsky; F A Lue
Journal:  Psychosom Med       Date:  1986 May-Jun       Impact factor: 4.312

4.  The MOS short-form general health survey. Reliability and validity in a patient population.

Authors:  A L Stewart; R D Hays; J E Ware
Journal:  Med Care       Date:  1988-07       Impact factor: 2.983

5.  The Brief Symptom Inventory: an introductory report.

Authors:  L R Derogatis; N Melisaratos
Journal:  Psychol Med       Date:  1983-08       Impact factor: 7.723

6.  The effect of sleep loss on high intensity exercise and recovery.

Authors:  R G McMurray; C F Brown
Journal:  Aviat Space Environ Med       Date:  1984-11

7.  Sleep deprivation, physical fatigue, and the perception of exercise intensity.

Authors:  W S Myles
Journal:  Med Sci Sports Exerc       Date:  1985-10       Impact factor: 5.411

Review 8.  Fibromyalgia syndrome. An emerging but controversial condition.

Authors:  D L Goldenberg
Journal:  JAMA       Date:  1987 May 22-29       Impact factor: 56.272

Review 9.  Sleep research in affective illness: state of the art circa 1987.

Authors:  C F Reynolds; D J Kupfer
Journal:  Sleep       Date:  1987-06       Impact factor: 5.849

10.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

View more
  18 in total

Review 1.  A systematic review of patient-reported outcome instruments measuring sleep dysfunction in adults.

Authors:  Emily Beth Devine; Zafar Hakim; Jesse Green
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

2.  Insomnia in the chronic fatigue syndrome.

Authors:  R Morriss
Journal:  BMJ       Date:  1993-07-24

3.  Sleep-stage dynamics in patients with chronic fatigue syndrome with or without fibromyalgia.

Authors:  Akifumi Kishi; Benjamin H Natelson; Fumiharu Togo; Zbigniew R Struzik; David M Rapoport; Yoshiharu Yamamoto
Journal:  Sleep       Date:  2011-11-01       Impact factor: 5.849

4.  Power spectral analysis of sleep EEG in twins discordant for chronic fatigue syndrome.

Authors:  Roseanne Armitage; Carol Landis; Robert Hoffmann; Martha Lentz; Nathaniel Watson; Jack Goldberg; Dedra Buchwald
Journal:  J Psychosom Res       Date:  2008-11-25       Impact factor: 3.006

5.  Heart rate variability during sleep and subsequent sleepiness in patients with chronic fatigue syndrome.

Authors:  Fumiharu Togo; Benjamin H Natelson
Journal:  Auton Neurosci       Date:  2013-03-15       Impact factor: 3.145

6.  A systematic review of chronic fatigue syndrome: don't assume it's depression.

Authors:  James P Griffith; Fahd A Zarrouf
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

Review 7.  Sleep abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: a review.

Authors:  Melinda L Jackson; Dorothy Bruck
Journal:  J Clin Sleep Med       Date:  2012-12-15       Impact factor: 4.062

Review 8.  Treatment of the chronic fatigue syndrome. A review and practical guide.

Authors:  E Blondel-Hill; S D Shafran
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

9.  Effects of captopril and oxygen on sleep apnoea in patients with mild to moderate congestive cardiac failure.

Authors:  J T Walsh; R Andrews; R Starling; A J Cowley; I D Johnston; W J Kinnear
Journal:  Br Heart J       Date:  1995-03

10.  Screening instruments for psychiatric morbidity in chronic fatigue syndrome.

Authors:  R K Morriss; A J Wearden
Journal:  J R Soc Med       Date:  1998-07       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.